IRIS
GALLO, Antonio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 3.223
NA - Nord America 2.306
AS - Asia 528
SA - Sud America 4
Continente sconosciuto - Info sul continente non disponibili 3
AF - Africa 1
OC - Oceania 1
Totale 6.066
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.297
IE - Irlanda 1.020
IT - Italia 845
GB - Regno Unito 340
UA - Ucraina 275
CN - Cina 236
DE - Germania 210
SG - Singapore 160
SE - Svezia 125
AT - Austria 104
TR - Turchia 91
FR - Francia 83
FI - Finlandia 79
GR - Grecia 69
BE - Belgio 22
NL - Olanda 15
KR - Corea 12
IR - Iran 10
CA - Canada 7
CZ - Repubblica Ceca 7
ES - Italia 6
JP - Giappone 6
RU - Federazione Russa 6
VN - Vietnam 6
CH - Svizzera 3
EU - Europa 3
IN - India 3
EC - Ecuador 2
HR - Croazia 2
IL - Israele 2
MX - Messico 2
PL - Polonia 2
RO - Romania 2
RS - Serbia 2
SM - San Marino 2
AL - Albania 1
AR - Argentina 1
AU - Australia 1
BR - Brasile 1
BY - Bielorussia 1
CY - Cipro 1
DZ - Algeria 1
MK - Macedonia 1
PK - Pakistan 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 6.066
Salva come PNG Salva come JPEG
Città #
Dublin 1.018
Jacksonville 448
Chandler 390
Princeton 131
Caserta 114
Ann Arbor 113
Roxbury 107
Singapore 107
Vienna 104
Medford 94
New York 88
Beijing 65
Bremen 64
Wilmington 60
Boardman 57
Woodbridge 56
Rome 44
Naples 43
Norwalk 42
Cambridge 41
Nanjing 41
San Mateo 40
Milan 32
Napoli 32
Des Moines 26
Brussels 22
London 21
Jinan 18
Mountain View 15
Shenyang 15
Ashburn 12
Houston 11
Redwood City 11
Seoul 11
Turin 11
Auburn Hills 10
Genoa 9
Lappeenranta 9
Düsseldorf 8
Falls Church 8
Munich 8
Aversa 7
Cercola 7
Fairfield 7
Kunming 7
Lanzhou 7
Sala Consilina 7
Brno 6
Dong Ket 6
Haikou 6
Nanchang 6
Santa Maria Capua Vetere 6
Verona 6
Bologna 5
Brescia 5
Groningen 5
Guangzhou 5
Hebei 5
Pisa 5
Reggio Emilia 5
Tokyo 5
Buffalo 4
Busto Arsizio 4
Florence 4
Gorgonzola 4
Gunzenhausen 4
Helsinki 4
Padova 4
Salerno 4
Shanghai 4
Taiyuan 4
Taizhou 4
Tianjin 4
Amsterdam 3
Bacoli 3
Bedford 3
Boydton 3
Buscate 3
Livorno 3
Luzzano 3
Ningbo 3
Nürnberg 3
Palermo 3
Parabiago 3
Phoenix 3
San Vito di Cadore 3
Siena 3
Tappahannock 3
Toronto 3
Trecase 3
Trentola-Ducenta 3
Treviso 3
Turi 3
Varedo 3
Washington 3
Zhengzhou 3
Acquaviva 2
Afragola 2
Appiano Gentile 2
Bitonto 2
Totale 3.799
Salva come PNG Salva come JPEG
Nome #
Anxiety in Multiple Sclerosis: Psychometric properties of the State-Trait Anxiety Inventory 474
Connectivity-based parcellation of the thalamus in multiple sclerosis and its implications for cognitive impairment: A multicenter study. 101
Computer-aided cognitive rehabilitation improves cognitive performances and induces brain functional connectivity changes in relapsing remitting multiple sclerosis patients: an exploratory study. 101
Visual resting-state network in relapsing-remitting MS with and without previous optic neuritis 98
Distributed changes in default-mode resting-state connectivity in multiple sclerosis 97
Dilated Virchow-Robin spaces and multiple sclerosis: 3 T magnetic resonance study. 95
Cognitive impairment and memory disorders in relapsing-remitting multiple sclerosis: the role of white matter, gray matter and hippocampus. 89
Attention and processing speed performance in multiple sclerosis is mostly related to thalamic volume 87
Default mode network changes in multiple sclerosis: A link between depression and cognitive impairment? 86
Psychometric properties and validity of Beck Depression Inventory II in multiple sclerosis. 80
Fatigue in multiple sclerosis: The contribution of occult white matter damage. 80
Advantages of QBI in TBSS analyses. 79
Frontotemporal cortical thinning in amyotrophic lateral sclerosis. 78
Clinical and magnetic resonance imaging predictors of disease progression in multiple sclerosis: a nine-year follow-up study. 74
Lesion load may predict long-term cognitive dysfunction in multiple sclerosis patients. 74
The role of diet in multiple sclerosis: A review 74
Cognitive reserve and neuropsychological performance in multiple sclerosis: A meta-analysis 72
INFRATENTORIAL PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY IN A PATIENT TREATED WITH FLUDARABINE AND RITUXIMAB 69
Quality of life in women with multiple sclerosis and overactive bladder syndrome 67
Dilated perivascular spaces and fatigue: is there a link? Magnetic resonance retrospective 3Tesla study 67
T(1) cortical hypointensities and their association with cognitive disability in multiple sclerosis 66
Functional correlates of cognitive dysfunction in multiple sclerosis: A multicenter fMRI Study. 65
Brain atrophy and fatigue in relapsing-remitting multiple sclerosis patients: a 3T study 65
BDNF Val66Met polymorphism and brain volumes in multiple sclerosis 65
Fatigue in multiple sclerosis: The contribution of resting-state functional connectivity reorganization 64
A simple measure of cognitive reserve is relevant for cognitive performance in MS patients 64
Thyroid autoimmunity and dysfunction in multiple sclerosis patients during long-term treatment with interferon beta or glatiramer acetate: an Italian multicenter study. 60
Axonal injury and overall tissue loss are not related in primary progressive multiple sclerosis 60
Proton spectroscopic imaging - Principles and clinical applications in neurology 60
Psychological consequences of COVID-19 pandemic in Italian MS patients: signs of resilience? 60
Endovascular treatment of CCSVI in patients with multiple sclerosis: clinical outcome of 462 cases. 59
Axonal injury in early multiple sclerosis is irreversible and independent of the short-term disease evolution 59
Assessing response to interferon-β in a multicenter dataset of patients with MS 59
A brain magnetization transfer MRI study with a clinical follow up of about four years in patients with clinically isolated syndromes suggestive of multiple sclerosis 58
dVRS and Fatigue: is there a link? Magnetic Resonance retrospective 3T study 58
Guidelines on the clinical use for the detection of neutralizing antibodies (NAbs) to IFN beta in multiple sclerosis therapy: report from the Italian Multiple Sclerosis Study group. 57
Grey matter damage predicts the evolution of primary progressive multiple sclerosis at 5 years 57
NEUROIMAGING NEI DISTURBI DELL’UMORE 56
Cognitive performance in multiple sclerosis: the contribution of intellectual enrichment and brain MRI measures 56
Malattie del Sistema nervoso Autonomo 53
Hippocampal and Deep Gray Matter Nuclei Atrophy Is Relevant for Explaining Cognitive Impairment in MS: A Multicenter Study 53
The Italian Neuroimaging Network Initiative (INNI): enabling the use of advanced MRI techniques in patients with MS 53
Regional brain atrophy evolves differently in patients with multiple sclerosis according to clinical phenotype 52
Hirayama disease: three cases assessed by F wave, somatosensory and motor evoked potentials and magnetic resonance imaging not supporting flexion myelopathy. 52
Multiparametric MRI in a patient with adult-onset leukoencephalopathy with vanishing white matter 52
Adverse events after endovascular treatment of chronic cerebro-spinal venous insufficiency (CCSVI) in patients with multiple sclerosis. 52
Regional changes in thalamic shape and volume are related to cognitive performance in multiple sclerosis 52
Clinically relevant cranio-caudal patterns of cervical cord atrophy evolution in MS 52
The effect of inflammation and its reduction on brain plasticity in multiple sclerosis: MRI evidence 50
A semiautomatic method for multiple sclerosis lesion segmentation on Dual-Echo MR imaging: Application in a multicenter context 50
Quality and Quantity of Diffuse and Focal White Matter Disease and Cognitive Disability of Patients with Multiple Sclerosis 49
Short-term accrual of gray matter pathology in patients with progressive multiple sclerosis: an in vivo study using diffusion tensor MRI 48
Extra-motor involvement in ALS patients: a cortical thickeness 3T MRI study 48
Cognitive impairment and its relation to imaging measures in multiple sclerosis: a study using a computerized battery. 47
The Contribution of Resting State Networks to the Study of Cortical Reorganization in MS. 47
Disease-Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis 46
Regional cortical thinning in multiple sclerosis and its relation with cognitive impairment: A multicenter study. 45
No evidence of disease activity (NEDA-3) and disability improvement after alemtuzumab treatment for multiple sclerosis: a 36-month real-world study 45
Structural MRI correlates of cognitive impairment in patients with multiple sclerosis: A Multicenter Study 44
Validity and reproducibility of the Italian version of the patient determined disease steps scale in people with multiple sclerosis 44
Does cognitive reserve play any role in multiple sclerosis? A meta-analytic study 44
Morphostructural MRI abnormalities related to neuropsychiatric disorders associated to multiple sclerosis. 43
Two-year macular volume assessment in multiple sclerosis patients treated with fingolimod 43
Functional plasticity of the visual system in multiple sclerosis. 42
Resting-State Functional Correlates of Social Cognition in Multiple Sclerosis: An Explorative Study 42
A cross-sectional, multicentre study of the therapeutic management of multiple sclerosis relapses in Italy. 41
A multiparametric brain and cord MR imaging study of a patient with Hirayama disease. 41
Mean diffusivity and fractional anisotropy histogram analysis of the cervical cord in MS patients 41
An MT MRI study of the cervical cord in clinically isolated syndromes suggestive of MS 40
Relationship of Cortical Atrophy to Fatigue in Patients With Multiple Sclerosis 37
NEURORADIOLOGIA E SCLEROSI MULTIPLA 37
"Better explanations" in multiple sclerosis diagnostic workup: A 3-year longitudinal study 37
The Relationships Between Cognitive Reserve and Psychological Symptoms: A Cross-Sectional Study in Healthy Individuals 37
Dimethyl fumarate vs Teriflunomide: an Italian time-to-event data analysis 37
Humoral response to SARS-CoV-2 mRNA vaccine in patients with multiple sclerosis treated with natalizumab 37
Correlates of executive functions in multiple sclerosis based on structural and functional mr imaging: Insights from a multicenter study 36
Health-Related Coping and Social Interaction in People with Multiple Sclerosis Supported by a Social Network: Pilot Study With a New Methodological Approach 36
Two Unexpected Cases of Rosacea during Fingolimod Therapy 36
Association of Gray Matter Atrophy Patterns With Clinical Phenotype and Progression in Multiple Sclerosis 36
Correction to: Prevalence and predictors of bowel dysfunction in a large multiple sclerosis outpatient population: an Italian multicenter study (Journal of Neurology, (2022), 269, 3, (1610-1617), 10.1007/s00415-021-10737-w) 36
Impaired metabolic capacity in the perirhinal and posterior parietal cortex lead to dissociation between attentional, motivational and spatial components of exploration in the Naples High-Excitability rat 35
Risk of multiple sclerosis relapses when switching from fingolimod to cell-depleting agents: the role of washout duration 35
Pyramidal tract lesions and movement-associated cortical recruitment in patients with MS 34
Six-month humoral response to mRNA SARS-CoV-2 vaccination in patients with multiple sclerosis treated with ocrelizumab and fingolimod 34
The effect of IFN-beta on black holes in patients with multiple sclerosis 33
Multiple sclerosis patients and immunomodulation therapies: the potential role of new MRI techniques to assess responders versus non-responders 33
The management of multiple sclerosis by reference centers in south of Italy: a 2011 survey on health demands and needs in Campania region. 33
Six-month humoral response to BNT162b2 mRNA COVID-19 vaccine in people with multiple sclerosis treated with natalizumab 33
The psychological impact of Covid-19 pandemic on people with Multiple Sclerosis: A meta-analysis 33
Diffusion-tensor magnetic resonance imaging detects normal-appearing white matter damage unrelated to short-term disease activity in patients at the earliest clinical stage of multiple sclerosis 31
A multicentRE observational analysiS of PErsistenCe to Treatment in the new multiple sclerosis era: the RESPECT study 31
Distinctive structural and functional MRI footprint for cognitive dysfunction in pediatric MS? 30
Characterizing 1-year development of cervical cord atrophy across different MS phenotypes: A voxel-wise, multicentre analysis 30
Coping strategies in relapsing-remitting multiple sclerosis non-depressed patients and their associations with disease activity 29
Characteristics and treatment of Multiple Sclerosis-related trigeminal neuralgia: An Italian multi-centre study 29
Exit Strategies in Natalizumab-Treated RRMS at High Risk of Progressive Multifocal Leukoencephalopathy: a Multicentre Comparison Study 28
Differential association of cortical, subcortical and spinal cord damage with multiple sclerosis disability milestones: A multiparametric MRI study. 28
Prognostic Markers of Ocrelizumab Effectiveness in Multiple Sclerosis: A Real World Observational Multicenter Study 28
Discontinuation of teriflunomide and dimethyl fumarate in a large Italian multicentre population: a 24-month real-world experience 27
Treatment of multiple sclerosis with rituximab: A multicentric Italian-Swiss experience 27
Totale 5.624
Salva come PNG Salva come JPEG
Categoria #
all - tutte 28.548
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.548
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020420 0 0 23 13 79 23 107 12 86 29 23 25
2020/2021830 59 3 76 61 185 16 122 87 17 81 93 30
2021/2022970 53 19 23 37 293 27 25 42 60 66 72 253
2022/20231.805 182 22 34 128 172 133 7 87 955 26 26 33
2023/20241.092 73 37 55 107 264 123 69 29 45 22 110 158
2024/202558 22 36 0 0 0 0 0 0 0 0 0 0
Totale 6.457